5 billion sugar-lowering god drug people will soon enter the office.
-
Last Update: 2020-07-17
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Pharmaceutical Network July 14 - Recently, Yichang Renfu Pharmaceuticals' hydrochloric acid metformin slow release tablets (acceptance number CYHS1900194) imitation 3 categories of listing applications into the administrative approval stage, is expected to be approved for listing in the near future-meter-net data show that in 2019 China's public medical institutions terminal metformin sales of more than 5.4 billion yuan, an increase of 19.22% yoy, metformin for the third batch of proposed harvest varietiesmetformin is an oral hypoglycemic drug, is one of the most commonly used oral hypoglycemic drugs in clinical use, and is also a first-line drug recommended by domestic and foreign guidelines for the treatment of diabetesmetformin hydrochloride is used to improve blood sugar control in patients with type 2 diabetes who are not satisfied with dietary controlaccording to-meter net data, in 2019, china's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (china's public medical institutions) terminal metformin sales of more than 5.4 billion yuan, an increase of 19.22 percent year-on-year, tablets accounted for 87.33 percent of the market share, capsules accounted for 12.67 percentthe sales of metformin (units: 10,000 yuan) in public medical institutions in China for the third batch of proposed collection varietiesthe current domestic market manufacturers of hydrochloric acid metformin slow release tablets in addition to the original research Merck Sherano, there are 47 generic pharmaceutical companies-meter internal network consistency evaluation database shows that hydrochloric acid metformin slow release film evaluation enterprises have 15Yichang Manfu Pharmaceuticals' hydrochloric acid metformin slow release film according to the new registration classification report, if successfully approved will be regarded as reviewed, win the collection of entry-level couponsthe slow release of metformin hydrochloride film evaluation enterprise source: minnet database.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.